Vteu protocol development, implementation and assays for study a prospective natural history study of US patients witha history of zika virus infection
Ended Awarded Last action
- Contract number
- HHSN27200011
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,355,536
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (VTEU) Award Notice · Posted Mar 29, 2012
- Contract value 70% obligated
-
- $2,355,536.10 Current, with exercised options
- $3,383,868.10 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$344,104 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$12,412 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $982,734 | |
| Original award | $1,729,319 |
About this award
This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $3,383,868.10, is for Emory University to provide protocol development, implementation, and assays for a prospective natural history study of U.S. patients with a history of Zika virus infection. The contract is not set aside and has an ultimate completion date of September 1, 2021. Emory University, a private research institution in Atlanta, Georgia, is the prime contractor on this award and has an extensive track record of conducting federally funded biomedical research, including work related to infectious diseases, for government agencies such as the NIH, Centers for Disease Control and Prevention, and Department of Defense.
Quick answers
Who was awarded contract HHSN27200011?
HHSN27200011 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 7, 2016.
How much is contract HHSN27200011 worth?
The government has obligated $2,355,536 on HHSN27200011. Its potential value, with all options, is $3,383,868.
Is contract HHSN27200011 an order under another contract?
Yes. HHSN27200011 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200011 competed?
The extent of competition for HHSN27200011 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award